GJ Lieschke, D Maher, J Cebon, M O'Connor, … - Annals of internal medicine, 1989 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Study Objective: To define the clinical and hematologic effects of ... Cited by 115 - Related articles - All 3 versions
WP Steward, JH Scarffe, R Austin, E Bonnem, … - British journal of cancer, 1989 - pubmedcentral.nih.gov Twenty patients with progressive metastatic solid tumours were entered into a
study to evaluate the biological effects and toxicity of recombinant human
granulocyte-macrophage colony-stimulating factor (GM-CSF). GM-CSF was given ... Cited by 58 - Related articles - All 3 versions
- ►aacrjournals.org [PDF] GJ Lieschke, D Maher, M O'Connor, M Green, … - Cancer Research, 1990 - AACR Clinical Research Program, Melbourne Tumor Biology Branch, Ludwig Institute for
Cancer Research ¡GJL, MO, AWB, GMJ and Departments of Diagnostic Hematology
¡DM, KMJ and of Hematology and Medical Oncology [M. G„W. S., RMF], ... Cited by 41 - Related articles - All 4 versions
WP Steward, JH Scarffe, LY Dirix, J Chang, … - British Journal of Cancer, 1990 - pubmedcentral.nih.gov Nine patients with progressive, metastatic disease from primary carcinoma of the
colon were entered into a phase I/II study using continuous intravenous
infusions of granulocyte-macrophage colony-stimulating factor (GM-CSF) and ... Cited by 29 - Related articles - All 3 versions
- ►bloodjournal.org [PDF] WP Peters, A Stuart, ML Affronti, CS Kim, RE … - Blood, 1988 - Am Soc Hematology . Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ... Cited by 70 - Related articles - All 5 versions
- ►jcojournal.org [PDF] F Herrmann, G Schulz, A Lindemann, W … - Journal of Clinical Oncology, 1989 - jcojournal.org The in vivo effect of yeast-derived recombinant human granulocyte-macrophage
colony-stimulating factor (rh GM-CSF) was investigated in 30 patients with
advanced malignancy in a phase Ib trial. Patients were treated at four ... Cited by 126 - Related articles - All 5 versions
- ►bloodjournal.org [PDF] N Phillips, S Jacobs, R Stoller, M Earle, D … - Blood, 1989 - Am Soc Hematology . Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ... Cited by 45 - Related articles - All 5 versions
- ►bloodjournal.org [PDF] J Nemunaitis, JW Singer, CD Buckner, R Hill … - Blood, 1988 - Am Soc Hematology . Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ... Cited by 167 - Related articles - All 9 versions
S Devereux, HA Bull, D Campos-Costa, R … - British journal of haematology, 1989 - ncbi.nlm.nih.gov The administration of recombinant human granulocyte-macrophage
colony-stimulating factor (rhGM-CSF) causes a transient leucopenia. Radionuclide
labelling studies showed this to be due to margination of neutrophils and ... Cited by 58 - Related articles
KS Antman, JD Griffin, A Elias, MA Socinski, L … - New England Journal of Medicine, 1988 - content.nejm.org An increase in the dose of chemotherapy enhances the response of many
experimental and clinical cancers, but the extent of dose escalation is often
limited by myelosuppression. In preliminary trials, recombinant human ... Cited by 437 - Related articles - All 4 versions
